NASDAQ: MGNX
Macrogenics Inc Stock Ownership - Who owns Macrogenics?

Insider buying vs selling

Have Macrogenics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jeffrey Stuart PetersSec;VP2026-08-1931,105$4.15
$129.09kSell
Ezio BonviniCSci;SVP2026-08-1740,000$2.60
$104.00kBuy
Thomas SpitznagelSr VP Technical Ops2026-02-155,520$1.71
$9.44kSell
Ezio BonviniSr VP Research CSO2026-02-156,433$1.71
$11.00kSell
James KarrelsSVP and CFO2026-02-155,790$1.71
$9.90kSell
Jeffrey Stuart PetersSenior VP GC and Secretary2026-02-155,147$1.71
$8.80kSell
Eric Blasius RisserPresident and CEO2026-02-156,433$1.71
$11.00kSell
Beth Ann SmithVP Controller Treasurer2026-02-15423$1.71
$723.33Sell
Ezio BonviniSr VP Research CSO2026-02-084,311$1.81
$7.80kSell
Beth Ann SmithVP Controller Treasurer2026-02-08612$1.81
$1.11kSell

1 of 2

MGNX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MGNX insiders and whales buy or sell their stock.

MGNX Shareholders

What type of owners hold Macrogenics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Target N. V. Biotech15.59%9,929,963$37.73MInsider
Tpg Group Holdings Sbs Advisors Inc3.47%2,208,762$8.39MInsider
Scott Koenig3.40%2,165,915$8.23MInsider
Alta Biopharma Partners III LP3.16%2,013,509$7.65MInsider
Interwest Partners VIII LP3.00%1,908,716$7.25MInsider
Edward Hurwitz2.75%1,752,820$6.66MInsider
Arnold L. Oronsky2.68%1,708,716$6.49MInsider
Kenneth Galbraith2.07%1,317,049$5.00MInsider
James Karrels0.48%306,368$1.16MInsider
Ezio Bonvini0.32%200,899$763.42kInsider

1 of 3

MGNX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MGNX0.08%37.81%Net SellingNet Buying
TRDA0.06%99.94%Net SellingNet Selling
CAMP0.07%49.92%Net SellingNet Selling
PYXS0.04%40.13%Net BuyingNet Buying
LCTX0.05%60.39%Net Selling

Macrogenics Stock Ownership FAQ

Who owns Macrogenics?

Macrogenics (NASDAQ: MGNX) is owned by 0.08% institutional shareholders, 37.81% Macrogenics insiders, and 62.11% retail investors. Target N. V. Biotech is the largest individual Macrogenics shareholder, owning 9.93M shares representing 15.59% of the company. Target N. V. Biotech's Macrogenics shares are currently valued at $37.73M.

If you're new to stock investing, here's how to buy Macrogenics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.